生物标志物模型区分心肌梗死类型与心肌损伤
本研究在急诊疑似心梗患者中评估29种生物标志物组合的判别价值,最终诊断依据第四版心肌梗死通用定义。748例患者中138例为心梗(107例1型、31例2型),221例为心肌损伤。多变量模型筛选出4种标志物区分1型与2型心梗(AUC 0.82),6种标志物区分心梗与心肌损伤(AUC 0.84),内部验证判别能力良好。
要点
- 4种生物标志物(ApoA-II、NT-proBNP、和肽素、hs-cTnI)可区分1型与2型心梗,内部验证AUC为0.82。
- 6种生物标志物(脂联素、NT-proBNP、PARC、运甲状腺素蛋白、和肽素、hs-cTnI)可区分心梗与心肌损伤,内部验证AUC为0.84。
- 基于29种标志物筛选的多变量模型对心梗分型与心肌损伤判别具有良好区分度。
核心结论
- 在29种生物标志物中筛选出7种与心梗亚型或心肌损伤判别最相关,基于这些标志物的回归模型具有良好区分能力。
研究设计与样本
- 前瞻性队列研究,纳入急诊疑似心肌梗死患者748例(中位年龄64岁),最终诊断依据第四版心肌梗死通用定义裁定。
- 检测29种生物标志物,采用多变量逻辑回归分析(后向选择法筛选变量),并通过自举法进行内部验证。
主要发现
- 748例患者中,138例发生心梗(107例1型心梗,31例2型心梗),221例发生心肌损伤。
- 多变量模型中,4种生物标志物(载脂蛋白A-II、N末端脑钠肽前体、和肽素、高敏心肌肌钙蛋白I)在区分1型与2型心梗中保持显著,内部验证AUC为0.82。
- 区分心梗与心肌损伤时,筛选出6种生物标志物(脂联素、N末端脑钠肽前体、肺与活化调节趋化因子、运甲状腺素蛋白、和肽素、高敏肌钙蛋白I),内部验证AUC为0.84。
临床怎么用
- 对于急诊疑似心梗患者,可考虑联合检测载脂蛋白A-II、NT-proBNP、和肽素和高敏肌钙蛋白I以辅助区分1型与2型心梗。
- 联合检测脂联素、NT-proBNP、PARC、运甲状腺素蛋白、和肽素和高敏肌钙蛋白I有助于鉴别心梗与心肌损伤。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Discrimination among patients with type 1 myocardial infarction (T1MI), type 2 myocardial infarction (T2MI), and myocardial injury is difficult. OBJECTIVES: The aim of this study was to investigate the discriminative value of a 29-biomarker panel in an emergency department setting. METHODS: Patients presenting with suspected myocardial infarction (MI) were recruited. The final diagnosis in all patients was adjudicated on the basis of the fourth universal definition of MI. A panel of 29 biomarkers was measured, and multivariable logistic regression analysis was used to evaluate the associations of these biomarkers with the diagnosis of MI or myocardial injury. Biomarkers were chosen using backward selection. The model was internally validated using bootstrapping. RESULTS: Overall, 748 patients were recruited (median age 64 years), of whom 138 had MI (107 T1MI and 31 T2MI) and 221 had myocardial injury. In the multivariable model, 4 biomarkers (apolipoprotein A-II, N-terminal prohormone of brain natriuretic peptide, copeptin, and high-sensitivity cardiac troponin I) remained significant discriminators between T1MI and T2MI. Internal validation of the model showed an area under the curve of 0.82. For discrimination between MI and myocardial injury, 6 biomarkers (adiponectin, N-terminal prohormone of brain natriuretic peptide, pulmonary and activation-regulated chemokine, transthyretin, copeptin, and high-sensitivity troponin I) were selected. Internal validation showed an area under the curve of 0.84. CONCLUSIONS: Among 29 biomarkers, 7 were identified to be the most relevant discriminators between subtypes of MI or myocardial injury. Regression models based on these biomarkers allowed good discrimination. (Biomarkers in Acute Cardiac Care [BACC]; NCT02355457).
引用
- Neumann JT, Weimann J, Sörensen NA, et al. A Biomarker Model to Distinguish Types of Myocardial Infarction and Injury. J Am Coll Cardiol. 2021. PMID: 34412811. doi:10.1016/j.jacc.2021.06.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。